The effect of polyphenolic extract from pine bark, Pycnogenol®, on the level of glutathione in children suffering from attention deficit hyperactivity disorder (ADHD)

Redox Report

Volumn 11, Issue 4, 2006, Pages 163-172

  Dvořáková, Monika ^a   Sivoňová, Monika ^a   Trebatická, Jana ^b   Škodáček, Igor ^b   Waczuliková, Iveta ^c   Muchová, Jana ^a   Duracková, Zdeňka ^a  

^a Comenius University ^*  (Slovakia)

^b UNIVERSITY HOSPITAL BRATISLAVA   (Slovakia)

^c Physics and Informatics   (Slovakia)

Author keywords

ADHD; Glutathione; Oxidative stress; Pycnogenol; TAS

Indexed keywords

ANTIOXIDANT; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; BIOFLAVONOID; CATECHIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; GLUTATHIONE; GLUTATHIONE DISULFIDE; LIPID; PHENOL DERIVATIVE; PLACEBO; PROCYANIDIN; PYCNOGENOL; SUPEROXIDE DISMUTASE; URIC ACID;

ADOLESCENT; ANTIOXIDANT ACTIVITY; ARTICLE; ATTENTION DEFICIT DISORDER; BARK; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; ENZYME ACTIVITY; FEMALE; HEREDITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PATHOGENESIS; PINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; TREATMENT OUTCOME;

ADOLESCENT; ANTIOXIDANTS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOUBLE-BLIND METHOD; FEMALE; FLAVONOIDS; GLUTATHIONE; GLUTATHIONE DISULFIDE; HUMANS; MALE; OXIDATION-REDUCTION; OXIDATIVE STRESS; PHYTOTHERAPY; PINUS; PLANT BARK; TIME FACTORS; TREATMENT OUTCOME;

EID: 33748998190     PISSN: 13510002     EISSN: 13510002     Source Type: Journal    
DOI: 10.1179/135100006X116664     Document Type: Article

References (45)

1. Sies H. (ed) Oxidative Stress: Oxidants and Prooxidants. London: Academic Press, 1999.
2. Ďurčková Z. Vol'né radikály a antioxidanty v medicine II. Slovak Academic Press, 1999; 1-315.
3. Sivoňová M, Žitňanová I, Hlinčiková L, Škodácek I, Trebatická J, Ďuračková Z. Oxidative stress in university students during examinations. Stress 2004; 7: 183-188.
4. Sirota P, Gavriely R, Wolach B. Overproduction of neutrophil radical oxygen species correlates with negative symptoms in schizophrenic patients: parallel studies on neutrophil chemotaxis, superoxide production and bactericidal activity. Psychiatry Res 2003; 121: 123-132.
5. Barkley RA. Attention Deficit Hyperactivity Disorder: A Handbook for Diagnosis and Treatment. New York: Guilford Press, 1990.
6. Kaminester DD. Attention deficit hyperactivity disorder and methylphenidate: when society misunderstands medicine. J Med 1997; 3: 105-114.
7. Anastopoulos AD, Shelton TL. Assessing Attention - Deficit/Hyperactivity Disorder. New York: Kluwer/Plenum, 2001; 1-349.
8. Gillberg C, Gillberg IC, Rasmussen P et al. Co-existing disorders in ADHD - implications for diagnosis and intervention. Eur Child Adolesc Psychiatry 2004; 13: 180-192.
9. Grima G, Benz B, Parpura V, Cuénod M, Do KQ. Dopamine - induced oxidative stress in neurons with glutathione deficit: implication for schizophrenia, Schizophr Res 2003; 62: 213-224.
10. Baez S, Segura-Aguilar J, Widersten M, Johansson AS, Mannervik B. Glutathione transferases catalyse the detoxication of oxidized metabolites (o-quinones) of catecholamines and may serve as an antioxidant system preventing degenerative cellular processes. Biochem J 1997; 324: 25-28.
11. Smythies J. Redox aspects of signaling by catecholamines and their metabolites. Antioxid Redox Signal 2000; 2: 575-83.
12. Do KQ, Trabesinger AH, Kirsten-Kruger M et al. Schizophrenia: glutathione deficit in cerebrospinal and prefrontal cortex in vivo. Eur J Neurosci 2000; 12: 3721-3728.
13. Chovanová Z, Muchová J, Sivoňová M et al. Effect of polyphenolic extract, Pycnogenol®, on the level of 8-oxoguanine in children suffering from attention deficit/hyperactivity disorder. Free Radic Res 2006; In press.
14. Trebatická J, Kopasová S, Hradečná Z et al. Treatment of ADHD with French maritime pine bark extract, Pycnogenol®. Eur Child Adolesc Psychiatry 2006; In press.
15. Simpson D, Plosker GL. Atomoxetine: a review of its use in adults with attention deficit hyperactivity disorder. Drugs 2004; 64: 205-222.
16. Jeng W, Wong AW, Ting-A-Kee R, Wells PG. Methamphetamine - enhanced embryonic oxidative DNA damage and neurodevelopmental deficits. Free Radic Biol Med 2005; 39: 317-326.
17. Passwater RA. All about Pycnogenol®. New York: Avery, 1998.
18. Heimann S. Pycnogenol® for ADHD? J Am Child Adolesc Psychiatry 1999; 38: 357-358.
19. Masao H. Pycnogenol®'s therapeutic effect in improving ADHD symptoms in children. Mainichi Shimbun, 21 October 2000.
20. Tenenbaum S, Paull JC, Sparrow EC, Dodd DK, Green L. An experimental comparison of Pycnogenol® and methylphenidate in adults with attention-deficit/hyperactivity disorder (ADHD). J Atten Disord 2002; 6: 49-60.
21. Packer L, Rimbach G, Virgili F. Antioxidant activity and biologic properties of a procyanidine-rich extract from pine (Pinus maritima) bark, Pycnogenol®. Free Radic Biol Med 1999; 27: 704-724.
22. Fitzpatrick DF, Bing B, Rohdewald P. Endothelium-dependent vascular effects of Pycnogenol®. J Cardiovasc Pharmacol 1998; 32: 509-515.
23. Rohdewald P. In: Coates PM, Blackman MR, Cragg G, Levine M, Moss J, White J. (eds) Encyclopedia of Dietary Supplements. New York: Marcel Dekker, 2005; 545-553.
24. Berryman AM, Maritim AC, Sanders RA, Watkins 3rd JB. Influence of treatment of diabetic rats with combinations of Pycnogenol, beta-carotene and alpha-lipoic acid on parameters of oxidative stress. J Biochem Mol Toxicol 2004; 18: 345-352.
25. Kobayashi MS, Han D, Packer L. Antioxidants and herbal extracts protect HT-4 neuronal cells against glutamate-induced cytotoxicity. Free Radic Res 2000; 32: 115-124.
26. Sastre J, Pallardo FV, Vina J. Glutathione, oxidative stress and aging. Age 1996; 19: 129-139.
27. Dabrosin Ch, Öllinger K. Variability of glutathione during menstrual cycle - due to estrogen effects on hepatocytes? Free Radic Biol Med 2004; 36: 145-151.
28. Kidd PM. Glutathione: systemic protectant against oxidative and free radical damage. Altern Med Rev 1997; 1: 155-176.
29. Filomeni G, Rotilio G, Ciriolo MR. Cell signaling and the glutathione redox system. Biochem Pharmacol 2002; 64: 1057-1064.
30. Asensi M, Garcia-España, Pallardó FV, Viña J, Estrela JM. Effect of non-protein thiols on protein synthesis in isolated rat hepatocytes. Experientia 1996; 52: 111-114.
31. Schmitt-Schillig S, Schaffer S, Weber CC, Eckert GP, Müller WE Flavonoids and the aging brain. J Physiol Pharmacol 2005; 56: 23-26.
32. Ferrer JV, Sastre J, Pallardó FV et al. Senile cataract: a review on free radical related pathogenesis and antioxidant prevention. Arch Gerontol Geriatr 1991; 13: 51-59.
33. Sastre J, Asensi M, Gascó E et al. Exhaustive physical exercise causes oxidation of glutathione status in blood: prevention by antioxidant administration. Am J Physiol 1992; 263: 992-995.
34. Ďurčková Z, Križková L, Maruniaková A. Biological activities of natural polyphenols (Pycnogenol® and Egb761) and their interaction with vitamin C and E. XXI International Conference on Polyphenols. Morocco: Marrakech, 2002; 315-316.
35. Ďuračková Z, Rohdewald P, Muchová J et al. Supplementation with Pycnogenol® French maritime pine bark extract reduces markers of oxidative stress in children with attention deficit hyperactivity disorders (ADHD). 2nd International Conference on Polyphenols and Health. Supplemental Abstracts. Davis: University of California, 2005.
36. Reed DJ, Babson JR, Beatty PW, Brodie AE, Ellis WW, Potter DW. High performance liquid chromatography analysis of nanomole levels of glutathione, glutathione disulfide and related thiols and disulfides. Anal Biochem 1980; 106: 55-62.
37. Barnett V, Lewis, T. Outliers in Statistical Data, 3rd edn. New York: Wiley, 1994.
38. Lang CA, Mills BJ, Mastropaolo W, Liu MC. Blood glutathione decrease in chronic diseases. J Lab Clin Med 2001; 135: 402-405.
39. Jacobsen JP, Rodriguiz RM, Mork A, Wetsel WC. Monoaminergic dysregulation in glutathione-deficient mice: possible relevance to schizophrenia? Neuroscience 2005; 132: 1055-1072.
40. Castagne V, Rougemont M, Cuenod M, Do KQ. Low brain glutathione and ascorbic acid associated with dopamine uptake inhibition during rat's development induce long-term cognitive deficit: relevance to schizophrenia. Neurobiol Dis 2004; 15:93-105.
41. Myhrstadt MC, Carlsen H, Nordstrom O, Blomhoff R, Moskaug JO. Flavonoids increase the intracellular glutathione level by transactivation of the γ-glutamylcysteine synthetase catalytical subunit promoter. Free Radic Biol Med 2002; 32: 386-393.
42. Carlsen H, Myhrstad MC, Thoresen M, Moskaug JO, Blomhoff R. Berry intake increases the activity of the γ-glutamylcysteine synthetase promoter in transgenic reporter mice. J Nutr 2003; 133: 2137-2140.
43. Ďuračková Z, Muchová J, Sivoñová M et al. Oxidative stress in pathophysiology of attention deficit hyperactivity disorder and its influence by a polyphenolic natural extract, Pycnogenol®. XXII International Conference on Polyphenols, Helsinki, Finland, August 25-28 2004, P37, 177-178.
44. Siler-Marsiglio KI, Paiva M, Madorsky I, Serrano Y, Neelez A, Heaton MB. Protective mechanisms of Pycnogenol® in ethanol-insulted cerebellar granule cells. J Neurobiol 2004; 61: 267-276.
45. Wei YH, Peng QL, Lau BHS. Pycnogenol® enhances endothelial cell antioxidant defenses. Redox Report 1997; 3: 219-224.